Aptamer-based therapeutics: new approaches to combat human viral diseases - Wikidata - awgldk - TriplyDB

Aptamer-based therapeutics: new approaches to combat human viral diseases

Aptamer-based therapeutics: new approaches to combat human viral diseases

http://www.wikidata.org/entity/Q37415958

about

Monitoring Intact Viruses Using Aptamers.G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents Fitness Landscapes of Functional RNAs Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch the activity of TBA from anticoagulant to antiproliferative.EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model Discovery and Characterization of a Novel CD4-Binding Adnectin with Potent Anti-HIV Activity.Oligonucleotide aptamers: potential novel molecules against viral hepatitis.Aptamers as targeted therapeutics: current potential and challenges.Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.Aptamers against pathogenic microorganisms.Biomedical Applications of DNA-Conjugated Gold Nanoparticles.Advances in the development of aptamer drug conjugates for targeted drug delivery.Incorporation of aptamers in the terminal loop of shRNAs yields an effective and novel combinatorial targeting strategy.RNA Interference Therapies for an HIV-1 Functional Cure.Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics.Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.

P2860

Q26741381-DBCF1276-1519-407E-86B2-B940176F7A57 Q26781549-373F1046-9653-4756-B102-0FC68041C56B Q26797312-5E9864F5-8549-4DD6-940E-E3280602C286 Q28079654-0035B9E8-6437-413D-90C3-DA8701E5984C Q35205365-33514E2B-F91A-4D96-A681-CD0910EF6AF8 Q36299184-8D9A6404-11EE-4F94-8344-928323A3A8F5 Q36352817-18CB0813-1F74-487F-9D17-EFD4F9174987 Q36393594-2C51DA9E-3A2D-456C-B829-FC898540C7A2 Q37743634-AC3D8B82-E4B7-419A-9C83-BBD16BDB19A5 Q38290290-29044A13-C322-4008-BAA9-2719F700D340 Q38443249-6F6D17D5-5CEF-405B-AA94-EEFF05E98627 Q38563672-C88B090C-5A36-4C04-8FDB-5342184B74A5 Q38728691-6E1F172D-C68E-47E6-935F-3DA9FD78EDD6 Q38995729-A9F926A8-6949-4954-91F5-67D116E0FCF4 Q45873648-E74A41E0-6995-4447-9BA8-678919BB4427 Q47252129-43CED99E-00E5-41D2-BE04-751A8D58526E Q48087924-0A5802FE-9A63-4245-9BEA-61A66E3185C5 Q55343646-77CFB13F-B157-43FD-94D1-6A9AB192181E

P2860

Aptamer-based therapeutics: new approaches to combat human viral diseases

http://www.wikidata.org/entity/Q37415958

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Aptamer-based therapeutics: new approaches to combat human viral diseases

@en

Aptamer-based therapeutics: new approaches to combat human viral diseases.

@nl

type

label

Aptamer-based therapeutics: new approaches to combat human viral diseases

@en

Aptamer-based therapeutics: new approaches to combat human viral diseases.

@nl

prefLabel

Aptamer-based therapeutics: new approaches to combat human viral diseases

@en

Aptamer-based therapeutics: new approaches to combat human viral diseases.

@nl

P1433

Q37415958-D4888A52-39AF-4DF9-8EB1-C3EF99BFB3CA

P1476

Q37415958-1343849E-D853-4E4F-AAFD-61440EFA8480

P2093

Q37415958-8AC621EC-5E78-466A-958E-17794A9EFEF1

Q37415958-E336E205-8AA3-4E63-8A09-82CB08AAB71E

Q37415958-FCEC5AEC-375C-49D8-9297-4CEF1EE42212

P2860

Q37415958-00BA74BB-7E31-4676-9A75-60D3B46D8EA3

Q37415958-037E1FAA-3290-412B-90D1-20E79799BFA0

Q37415958-06188496-F145-42BD-B8D8-947551F3C0C5

Q37415958-0794217D-9B21-4853-989B-B47C9B3F4E35

Q37415958-07F2E05A-99BB-4358-BB48-44D7141F467A

Q37415958-089A0B82-C7F7-447E-8377-1579AF69BFB3

Q37415958-097EDB56-BDDD-4543-93DB-16C8B8135EBA

Q37415958-0A7EC041-F96A-4AC9-9485-FC123104883B

Q37415958-0AF67143-6E3B-4EFA-B629-1833A8B0079B

Q37415958-0C7F26DB-73CC-4FCB-A06E-71F489E94C3B

P304

Q37415958-A1AA7721-DDA0-4574-AA92-942656DDC720

P31

Q37415958-3E070996-F366-4469-9538-FF14FF217BED

P356

Q37415958-A9D34B51-B255-47FA-B281-D57183561B83

P433

Q37415958-081F630D-9335-40A2-A7A8-0F11059E4B8D

P478

Q37415958-CABEE3CF-F315-402B-88E7-8181B749217D

P577

Q37415958-F27A957E-4B61-4814-B825-34EB9BDDCA54

P5875

Q37415958-15043651-DEE1-469A-AB60-6B37B3216AE5

P698

Q37415958-AFADB6B7-E5DB-4FA7-B296-86F9B2E8F72F

P932

Q37415958-659FF6B9-36EF-4AB7-A3DA-A38B4E13FCE4

P356

P1433

Pharmaceuticals

P1476

Aptamer-based therapeutics: new approaches to combat human viral diseases

@en

P2093

Jiehua Zhou

http://www.w3.org/2001/XMLSchema#string

John J Rossi

http://www.w3.org/2001/XMLSchema#string

Ka-To Shum

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity

The emerging field of RNA nanotechnology

A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId

Rabies molecular virology, diagnosis, prevention and treatment

Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase

Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins

Internal ribosome entry site within hepatitis C virus RNA

Inhibition of Hepatitis C Virus (HCV) RNA Polymerase by DNA Aptamers: Mechanism of Inhibition of In Vitro RNA Synthesis and Effect on HCV-Infected Cells

Structural basis for discriminatory recognition of Plasmodium lactate dehydrogenase by a DNA aptamer

Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element

P304

1507-1542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH6121507

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259003033

http://www.w3.org/2001/XMLSchema#string

P698

24287493

http://www.w3.org/2001/XMLSchema#string

P932

3873675

http://www.w3.org/2001/XMLSchema#string